Quick News Spot

Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Purchased by Y Intercept Hong Kong Ltd


Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd boosted its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 760.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 111,979 shares of the company's stock after buying an additional 98,969 shares during the quarter. Y Intercept Hong Kong Ltd owned 0.23% of Nu Skin Enterprises worth $825,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Signaturefd LLC grew its position in shares of Nu Skin Enterprises by 72.6% during the second quarter. Signaturefd LLC now owns 3,797 shares of the company's stock worth $40,000 after buying an additional 1,597 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in Nu Skin Enterprises in the second quarter worth approximately $47,000. Headlands Technologies LLC grew its holdings in Nu Skin Enterprises by 1,428.0% during the 2nd quarter. Headlands Technologies LLC now owns 6,937 shares of the company's stock worth $73,000 after acquiring an additional 6,483 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Nu Skin Enterprises in the 2nd quarter valued at approximately $75,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of Nu Skin Enterprises in the 2nd quarter valued at $106,000. Hedge funds and other institutional investors own 82.84% of the company's stock.

NUS stock opened at $7.50 on Friday. The company's 50 day moving average is $6.89 and its two-hundred day moving average is $9.00. Nu Skin Enterprises, Inc. has a twelve month low of $5.95 and a twelve month high of $20.75. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. The stock has a market cap of $372.58 million, a P/E ratio of -3.62 and a beta of 1.20.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 11th. Shareholders of record on Friday, November 29th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.24 annualized dividend and a yield of 3.20%. Nu Skin Enterprises's dividend payout ratio is presently -11.59%.

NUS has been the subject of a number of analyst reports. StockNews.com upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, November 11th. Citigroup lowered their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a "neutral" rating for the company in a research report on Tuesday, October 22nd.

Read Our Latest Research Report on Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

3782

tech

4045

entertainment

4646

research

2047

misc

4911

wellness

3661

athletics

4775